">

Webinar: Advancing Molecular Glue Discovery Through High Throughput Mass Spectrometry Based Proteomics on Orbitrap Astral Mass Spectrometer

Molecular glues are monovalent small molecules with drug-like properties that alter the protein binding surface of E3 ligase, resulting in novel E3 ligase and target protein interactions. Molecular glues are difficult to design and are often discovered retrospectively. The rational design and discovery of molecular glues require an untargeted approach to understand the protein ternary complexes, target protein degradation, and ubiquitination induced by potential molecular glues. We have leveraged untargeted, high-throughput proteomic approaches to better understand protein-protein interactions and target protein degradation induced by prospective molecular glues. The recent developments in the field of high-throughput proteomics due to the introduction of faster and more sensitive mass spectrometers have brought us closer to the rational design and discovery of molecular glues.

 

Webinar learning objectives:

  • The use of mass spectrometry to perform Targeted Protein Degradation (TPD) studies.
  • Use of high-throughput proteomic approaches to better understand protein-protein interactions and target protein degradation induced by prospective molecular glues.
  • Learn about the novel Orbitrap Astral Mass Spectrometer and it's capabilities.

About the presenter

Sr Scientist Aman Makaju, Amgen, Discovery Proteomics Group, R&D

 

Aman Makaju plays a crucial role in supporting Amgen’s Drug Discovery pipeline through the application of mass spectrometry-based proteomics. He is an integral part of a dynamic team that has successfully developed a cutting-edge, high-throughput mass spectrometry-based proteomics platform.

Register to view the free on-demand webinar


This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

">